Hypertrophic cardiomyopathy (HCM) is a hereditary disease characterized by cardiac hypertrophy with diastolic dysfunction. Gene mutations causing HCM have been found in about half of the patients, while the genetic etiology and pathogenesis remain unknown for many cases of HCM. To identify novel mechanisms underlying HCM pathogenesis, we generated a cardiovascular-mutant medaka fish non-spring heart (nsh), which showed diastolic dysfunction and hypertrophic myocardium. The nsh homozygotes had fewer myofibrils, disrupted sarcomeres and expressed pathologically stiffer titin isoforms. In addition, the nsh heterozygotes showed M-line disassembly that is similar to the pathological changes found in HCM. Positional cloning revealed a missense mutation in an immunoglobulin (Ig) domain located in the M-line-A-band transition zone of titin. Screening of mutations in 96 unrelated patients with familial HCM, who had no previously implicated mutations in known sarcomeric gene candidates, identified two mutations in Ig domains close to the M-line region of titin. In vitro studies revealed that the mutations found in both medaka fish and in familial HCM increased binding of titin to muscle-specific ring finger protein 1 (MURF1) and enhanced titin degradation by ubiquitination. These findings implicate an impaired interaction between titin and MURF1 as a novel mechanism underlying the pathogenesis of HCM.
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Introduction
Zebrafish is well established as a model vertebrate in gene function studies. 1, 2 The medaka fish,
Oryzias latipes, recently emerged as another important such model system, because of its smaller genome size and larger genome diversity. 3 In particular, medaka is an excellent model for studying the cardiovascular system, because the embryos are transparent and able to tolerate an absence of blood flow under sufficient oxygen delivery by diffusion. 4 It is therefore possible to attribute cardiac phenotype directly to particular genes by ruling out the secondary effect of hypoxia.
Hypertrophic cardiomyopathy (HCM) is characterized by cardiac hypertrophy accompanied by myofibrillar disarray and diastolic dysfunction. The first HCM-causing gene identified was a missense mutation in the cardiac β -myosin heavy chain gene. 5 Such causative mutations were also identified in genes encoding contractile apparatus of sarcomere, such as α -tropomyosin, cardiac troponin T, and cardiac myosin-binding protein-C, 6 whereby HCM was thought to result from compensation for dysregulated sarcomeric contractile function. An HCM-associated mutation [7] [8] [9] identified in the titin gene (TTN) was the first causative gene not encoding contractile apparatus, which implied the existence of a novel pathogenesis except the compensation of systolic dysfunction.
Titin is the largest known single protein and, after myosin and actin, the third most abundant protein of vertebrate striated muscle. Titin connects the Z-disc to the M-line region where titin filaments extending from the opposite sides of half-sarcomeres overlap. 10, 11 Titin provides a scaffold for the assembly of thick and thin filaments 12 and passive stiffness during diastole. 13 Recently, titin was proposed to function as a sarcomeric stretch sensor that regulates muscle protein expression and turnover. [14] [15] [16] Titin carries a kinase domain at the M-line-A-band transition zone, and adjacent to the kinase domain is a binding site for the MURF1, 17 where the mechanical load on the sarcomere is transmitted through titin and its interaction partners to the nucleus. Functional alteration due to the TTN mutations may increase passive tension upon stretching of the sarcomere. 8, 18 Titin is extensively modular in structure and can be thought of as a microscopic necklace comprising up to 166 copies of 90-95 amino acid residue repeats from the immunoglobulin (Ig) domains.
Generally, the Ig domains located in the highly repetitive A-band region of titin share high structural similarity. 19 However, a subset of Ig domains close to the titin kinase has unique structural features.
For instance, Ig-A169 provides a binding site for MURF1, 17, 19 a sarcomere-associated E3 ubiquitin ligase that conjugates ubiquitin to proteins destined for proteolysis. 20, 21 MURF1 belongs to the MURF family of proteins, which are transcribed from three genes, form heterodimers, 17 and interact with titin kinase. MURFs have also been proposed to regulate protein degradation and gene expression in muscle tissues. 15 Here, we identified the non-spring heart (nsh) medaka fish, a cardiovascular mutant with a missense mutation in an Ig domain located at the M-line-A-band transition zone of titin. The nsh fish show diastolic dysfunction and hypertrophic heart. To decipher the roles of titin in these pathological effects, we focused on the M-line-A-band transition zone and identified two mutations in other Ig domains of titin in familial HCM patients. These titin mutations both increased the binding of titin to MURF1 and enhanced the degradation of titin by ubiquitination. This is the first report suggesting that the impaired binding of MURF1 to titin is a novel pathogenesis causing HCM.
Results
Medaka nsh mutants showed hypertrophic heart and disrupted sarcomeric structure
In a previous screening for ENU-induced mutations of medaka fish, we identified several mutants with abnormal heart development phenotypes. 25 Among these, one mutant showed rigid hearts with hypertrophy. Because the mutant heart had lost elasticity and beat in a rigid manner, we designated it as non-spring heart (nsh). The nsh embryos were indistinguishable from their wild-type (WT) siblings up to the heart tube stage (48 hours) and there was no difference in the heart rate. However, after 72 hours, the nsh hearts showed increased thickening of the myocardial wall, especially in the atrium and even without blood flow ( Figure 1A and 1B). Despite these abnormalities, the mutant embryos survived until 8 days post fertilization (dpf), a stage around hatching, in a relatively healthy condition without forming pericardial edemas.
Blood flow was very slow or clogged around 3 dpf in the mutants due to defects in diastole (see supplemental Movies 1 and 2). However, hemoglobin activity was normal in both WT embryos and nsh mutants at 3 dpf based on an olto-dianisidine staining analysis (data not shown). After crossing with fli1-GFP transgenic medaka (Supplemental Figure I) , alkaline phosphatase staining analysis revealed normal vascular endothelial cells at 3 dpf and normal blood vessel formation in the nsh mutants. To estimate the number of cardiomyocytes, we crossed the nsh mutants with a Tg medaka (cmlc2:DsRed2-nuc) expressing DsRed in the cardiomyocyte nuclei ( Figure 1C and 1D). We counted the nuclei of cardiomyocytes using confocal images and found no difference in the numbers between WT and nsh mutants at 3 dpf ( Figure 1C through 1E).
In situ hybridization with cardiac-differentiation markers, atrial and ventricular myosin heavy chains and cardiac myosin light chain, demonstrated normal expression of sarcomeric proteins in the nsh mutant ( Figure 1F through 1I). A cardiac stretch marker, brain natriuretic peptide (bnp), is normally expressed at 3 dpf in the WT ventricle, but its expression was increased in the atrium of nsh mutants ( Figure 1J and 1K).
We then examined the sarcomeric structures of embryonic cardiomyocytes by transmission electron microscopy. Sarcomeric units of the WT cardiomyocytes at 5 dpf showed highly organized, precisely aligned thick and thin myofilaments, flanked by Z-discs and M-lines ( Figure 1L ). In the nsh homozygotes, cardiomyocytes appeared abnormal with loosely arranged contractile filaments, where thick and thin filaments were disassembled and Z-discs were not parallel ( Figure 1M ). We next analyzed the sarcomeric structure of adult cardiomyocytes in the WT and nsh heterozygotes ( Figure   1N and 1O respectively). Expression of sarcomeric α -actinin was maintained in the nsh heterozygotes, although with fewer striations and patchy staining ( Figure 1O ). Transmission electron microscopy demonstrated ruptured sarcomeric units with irregular and widened Z-discs and M-lines in the cardiomyocytes of nsh heterozygotes ( Figure 1P and 1Q). We have analyzed body weight and heart weight ratio at 3～4 month old adult medaka fish.and nsh heterozygotes heart showed heavier than 
TTN is the nsh gene
To identify the gene responsible for the nsh phenotype, we carried out positional cloning. We scored 2,016 fishes from nsh × nsh/+ crosses and found that the nsh phenotype was linked to the medaka linkage group 21, LG 21. Single-strand conformation polymorphism markers from introns 193-194 and 3'UTR of the TTN confined the nsh locus to a 19.0-kb critical region ( Figure 2A ). TTN was the only transcript identified in the nsh critical region. Analysis of cDNAs from the nsh mutant and several WT strains revealed an adenine to thymine transversion causing the substitution of D (aspartic acid)-23186 to V (valine) in the nsh titin ( Figure 2B ). Medaka titin is encoded by a single gene composed of 219 exons, and the nsh missense mutation was localized to TTN exon 204 near the MURF1 binding region that encoded an Ig domain ( Figure 2C ). Alignment of titin from several species revealed that the nsh mutation occurred at an evolutionary highly conserved amino acid residue ( Figure 2D ).
Protein turnover of the mutated Ig domain titin at the M-line-A-band transition zone was faster than that of WT Ig domain titin
To investigate the molecular mechanisms of TTN mutation as the nsh gene, we performed RT-PCR analysis of the N-terminal TTN, A-I junction TTN, TTN exon 204, and titin kinase domain in WT and nsh mutant embryos at 3 dpf. This analysis revealed unchanged expression levels of TTN mRNA in the nsh mutant compared to WT ( Figure 3A ).
Titin isoform shifts have been reported in pathologic conditions. [34] [35] [36] [37] [38] In cardiac muscle, the elastic region expresses two types of titin isoforms, termed N2B and N2BA, which arose from alternative splicing and result in titin molecules that contain either a unique N2B element and short PEVK region (N2B isoform) or unique N2B and N2A elements and a long PEVK region (N2BA isoform). 16 Predominant expression of the N2B isoform results in stiffer cardiac tissue, while the expression of N2BA isoform results in more compliant cardiac myofibrils. 39 Changes in the relative proportions of N2B and N2BA was paralleled by changes in diastolic stiffness. 40 The N2BA/N2B ratio in myocardium under conditions of diastolic heart failure is lower than that observed during systolic heart failure. 41 We detected different titin N2B isoform shifts between the WT and nsh mutants titin in the nsh heart, which would be associated with less elasticity and increased passive stiffness.
To analyze the expression of titin proteins in the nsh mutant, we conducted indirect immunofluorescence on 3 dpf embryos using an antibody to the A-I junction portion of titin. In WT, titin appeared as a regularly striated pattern between the sarcomeres of adjacent myofibrils ( Figure 3C ).
However, the nsh mutants showed severely decreased titin immunofluorescence at the A-I junction ( Figure 3D ). Analysis of titin C-terminal region and α -actinin staining demonstrated an altered muscle organization, but there was no apparent decrease in expression of the titin C-terminal portion ( Figure   3E , 3F and Supplemental Figures II) . These findings indicated that certain titin isoforms at the A-I junction were selectively perturbed.
To further investigate the dominant-negative effect of mutant TTN in vivo, we overexpressed the Ig domain of TTN (GFP-tagged WT-TTN-A156 or E29783V-TTN-A156 construct, which was the equivalent of D23186V mutation in medaka ) ( Figure 3 ) by injecting mRNA corresponding to exon 204, in which the missense mutation was found, fused with the GFP fragment into one-cell-stage medaka embryos. Neither the WT-nor nsh-Ig domain induced a specific cardiac phenotypes (n = 200 in each case). However, in the nsh-Ig domain-injected medaka embryos, the GFP signal disappeared faster than in the WT Ig domain-injected embryos ( Figure 3G through 3J), demonstrating that the nsh-Ig domain was susceptible to degradation and/or was unstable in vivo. The nsh-Ig domain fragments could not be observed 2 days after the injection, before the heart beating, and this could explain why we could not replicate the nsh phenotype in the injected embryos ( Figure 3G through 3J).
Next we examined the faster turnover of the nsh-Ig titin domain, focusing on the ubiquitin proteasome (UPS) system because of the proximity of the nsh mutation to the MURF1 binding site.
We found that the nsh-Ig domain protein was degraded faster via the UPS-dependent pathway in vitro than the WT Ig domain ( Figure 3K ), and that this effect was rescued by the UPS inhibitor, epoxomicin ( Figure 3K ), indicating the turnover of this specific titin Ig domain is controlled by the UPS. This regulation mechanism could involve MURF1 because it is thought to act in muscle as a rate-limiting E3 ligase to initiate UPS-mediated degradation.
Medaka nsh mutants showed rigid hearts with normal heart rhythm
We quantified cardiac systolic and diastolic motion of WT and nsh mutants (see supplemental Movies 1 and 2) using high-speed video imaging and the analysis with motion vector prediction (MVP) method as described in the materials and methods section. This method could extract contraction and relaxation motions of cardiomyocytes non-invasively, and evaluate characteristics such as beating rate, orientation of contraction, beating homogeneity, and wave propagation of contraction. 42 As shown in Figure 4B and C, maximum systolic and diastolic velocities of atrium were decreased from ~183 μ m/sec in WT embryos to ~64 μ m/sec in nsh mutant and from ~140 μ m/sec in WT embryos to ~35 μ m/sec in nsh mutant, respectively, while the heart rate between WT and nsh mutant was not changed significantly. Although the maximum systolic and diastolic velocities of WT ventricle showed similar values with those of atrium, such velocities of nsh mutant was lower than those of atrium, i.e., ~29 μ m/sec for systole and ~22 μ m/sec for diastole ( Figure 4C ). These data demonstrated that nsh mutated gene was not required for the establishment of cardiac rhythm, but rather for control the cardiac elasticity ( Figure 4B ). To confirm if exaggerated degradation was responsible for the phenotype of nsh, we performed a rescue experiment with morpholino knockdown of MURF1. After the injection of morphlino we have analysis of cardiac movement by motion vector analysis. We could not suppress the nsh phonotype of cardiac hypertrophy even at a sub-lethal concentration however we could suppress the cardiac rigidity by MURF1 knockdown in nsh mutant. Cardiac hypertrophy is probably the later stages phenotype than cardiac rigidity and morphlino last in medaka embryo.
Next we investigated the binding between MURF1 and Ig domain with or without the mutations using the coimmunoprecipitations (co-IP) assays, and found that co-IPs from cells transfected with the myc-tagged MURF1 construct in combination with GFP-tagged WT-TTN-A156 or E29783V-TTN-A156 construct revealed that the A156 domain bound MURF1 and that the E29783V mutation significantly increased the binding (9.23+/-2.11 AU, P<0.001) ( Figure 4L and 4M). Notably, the expression level of mutant-TTN-A156 was lower than that of WT-TTN-A156 ( Figure 6L ).
Taken together, our data indicate that the Ig domain of the M-line-A-band transition zone of titin plays an important role in maintaining and organizing the myofibril structure. The severely reduced titin protein levels in combination with the genetic linkage data strongly implicated the TTN mutation as causative for the nsh phenotype. The alternations in N2B/N2BA titin isoforms in the nsh phenotype in turn underscored the probable key role of titin in regulating and maintaining cardiac muscle elasticity.
Mutational analysis of the human titin gene around the MURF1 binding domain in patients with familial hypertrophic cardiomyopathy
The proximity of the nsh mutation to the titin-MURF1 binding domain and the cardiac phenotype in mutant medaka implicated the titin M-line-A-band transition zone as a candidate region for mutations associated with HCM in humans. We therefore analyzed a total of 96 genetically unrelated Japanese patients with familial HCM, who carried apparent family history of HCM consistent with an autosomal dominant trait. They were diagnosed with HCM according to the diagnostic criteria as described previously. 33 They had been analyzed for mutations in the known disease genes for HCM, i.e., genes for contractile elements (MYH7, TNNT2, MYBPC3, TNNI3, MYL2, MYL3, ACTC1, TNNC1), Z-disc elements, and I band elements, and no disease-associated mutation was found. 33
Control subjects were 400 healthy Japanese individuals selected at random.
Exon 204 of medaka TTN containing the nsh mutation corresponds to exon 297 of human TTN, thus we searched for mutations in the patients by direct sequencing of exons 296-307 of TTN (GenBank Accession No. NM_133378), which encoded for the A-band-M-line transition region of titin including the titin-kinase domain. We identified two disease-associated missense mutations ( Figure 5A ):
TCT→GCT leading to the replacement of serine with alanine at position 30186 (S30186A) in exon 301 ( Figure 5B ), and GAT→AAT with the exchange of aspartic acid for asparagine at position 30994 (D30994N) in exon 306 ( Figure 5C ). The proband patients and their affected relatives were heterozygous for the mutations, and both mutations affected highly conserved amino acids. Quite interestingly, the latter mutation in the M-line-A-band transition zone of titin was mapped within the binding site for MURF1. It should be noted here that all three mutations found in medaka nsh mutant and human HCM patients were located in the Ig domains ( Figure 5A ).
Altered binding of titin to MURF1 caused by the TTN mutations
Based on the D30994N mutation being located in the MURF1 binding Ig domain of titin, A168-170, we investigated a possible functional change in binding to MURF1 due to the mutation. GFP-tagged WT-or D30994N-TTN-A168-170 construct was co-transfected with a myc-tagged MURF1 construct into COS-7 cells. Western blot (WB) analysis of co-IPs of the transfected cells using anti-myc antibody demonstrated that the D30994N mutation significantly increased binding to MURF1 1 0
(1.58+/-0.19 AU, P<0.01) ( Figure 6A and 6B). The A168-170 domain contains two Ig domains, A168
and A169, of which the A169 domain is the predominant binder of MURF1, 19 despite the D30994N mutation being located in the A168 domain. To further characterize the increased binding of titin to MURF1 in the presence of the D30994N mutation, we performed additional WB analyses of co-IPs from the cells transfected with the myc-tagged MURF1 construct in combination with GFP-tagged WT-TTN-A168, D30994N-TTN-A168, or WT-TTN-A169 constructs. WT-TTN-A169 showed significantly higher binding to MURF1 than WT-TTN-A168 (6.69+/-1.53 AU, P<0.01) ( Figure 6C and   6D ). On the other hand, the D30994N mutation also significantly increased the binding of A168 domain to MURF1 (3.06+/-0.68 AU, P<0.01) ( Figure 6C and 6D ).
Because the other mutation also located in the Ig domain, we also investigated the binding between MURF1 and other Ig domain with or without the mutation using the co-IP assays. The co-IPs from cells transfected with the myc-tagged MURF1 construct in combination with GFP-tagged WT-or S30186A-TTN-A160-161 construct revealed that the A160-161 domains also bound MURF1 and that the S30186A mutation significantly increased the binding (3.11+/-0.71 AU, P<0.001) ( Figure 6E Figure 6G ).
Moreover to confirm this idea, we also performed immuno-electron microscopy with anti-ubiquitin antibodies in WT and MURF1 knock-out mouse. 20 Ubiquitin signals was detected at the Z-line, central I-band and M-line regions in WT sarcomere. It was hard to quantify the signals, however ubiquitin seemed to be reduced in MURF1 knock-out mice at the M-line region (data not shown). Endogenous MURF1 levels were tightly regulated, 17 in combined with ubiquitination of titin A168-170 fragment by MURFs ( Figure 6G ), reduced ubiquitin signals of immuno-electron microscopy and increased binding of titin and MURF1 ( Figure 4L , 6A, 6C and 6E) suggested that the interactions of MURF1 with titin are critical for maintaining the stability of titin.
Discussion
We generated a cardiovascular-mutant nsh medaka fish by ENU mutagenesis that developed hypertrophy and diastolic dysfunction, and identified a causative mutation in a region of titin around the MURF1 binding site. The nsh homozygous fish showed loosely arranged contractile units, and died around 8 dpf. The nsh heterozygotes showed normal life span and fertility, but they exhibited M-line disassembly in myofibrils, indicating that the phenotype of M-line disassembly was inherited as a dominant trait.
Due to the extremely large size and presence of multiple isoforms, it has been difficult to study the structure and function of titin. A knock-in mouse of eGFP to titin gene showed that sarcomeric titin is more dynamic than previously suggested. 42 The large cardiac titin N2BA isoform is rapidly replaced by the smaller N2B isoform both after birth and with re-expression of the fetal gene program in cardiac pathologic conditions. 34-38 The isoform switch plays an important role in adjusting diastolic function. It has been used with knock-out technology to gain insight into the roles of titin in sarcomere assembly, stability and mechanotransduction during muscle pathophysiology. [43] [44] [45] Based on these studies, it was proposed that titin provides a scaffold for the developing sarcomere, 12 and that passive forces maintain the correct localization of M-lines and tether various signaling and structural molecules. 11 Multiple interacting proteins integrate titin into the sarcomere and modulate the titin filament with links to basic cellular functions including trophic signaling and energy balance.
Herman et al. 46 recently showed by next-generation sequencing that TTN truncating mutations are the most common known genetic cause of dilated cardiomyopathy (DCM). Their findings revealed that mutations associated with DCM were overrepresented in the titin A-band, but were absent around the M-band regions of titin. One may therefore speculate that some truncated titin peptides are degraded via the RNA-and protein-surveillance pathways in DCM. The consequently decreased titin levels could limit sarcomere formation resulting in cardiac dysfunction. However, this is not the case for previously reported TTN mutations that delete only part of the M-band portion of titin 47 ;
immunohistochemical studies showed that some of these carboxy-terminal truncated titin proteins are integrated into the sarcomere. If more proximal TTN truncating mutations caused DCM through haploinsufficiency, the distribution of such mutations would be rather uniform across the susceptible portion of titin.
The current study of our HCM families found point mutations around the M-line-A-band transition zone, which is implicated in sensing and modulating sarcomeric force. These mutations also induced high binding affinity between titin and MURF1. Using the medaka fish and our in vitro system, we showed that mutated titin fragments are degraded faster by ubiquitination. This study indicate that titin proteins found in families with HCM, as in the carboxy-terminal titin truncations studied, are integrated into sarcomeres and cause HCM via a dominant negative mechanism. Our results indicated that titin protein mutations in HCM families could be incorporated into the sarcomere and impair MURF1 binding, resulting in HCM through disturbance of the normal turnover of titin and abnormal sarcomere stiffness.
Until now, altered binding of MURF1 to titin has not been identified to be closely associated with human HCM or diastolic dysfunction. In this study, we analyzed exons 296-307 (M-line-A band transition zone) of TTN for mutations in patients with familial HCM and identified two disease-associated missense mutations in the Ig domains. One of the TTN mutations in familial HCM was in a binding site for MURF1. Although MURF1 binds to the Ig domain of the M-line-A-band transition region, A168-170, MURF1 was not considered to target titin for degradation. 17 Data in this study and previous studies indicate MURF1 may regulate the turnover of critical sarcomeric proteins 21 including some titin isoforms ( Figure 4C and 4D) . 20, 32 We also found that all the TTN mutations associated with HCM both in medaka and human in the Ig domains of the M-line-A-band transition zone increased the binding of MURF1 to titin ( Figure 6A, 6C and 6E ). In addition, the TTN constructs carrying the HCM-associated mutations expressed less amount of protein when they were injected into medaka embryos and transfected into cells ( Figure 4G , 4H, 4I, 4J, 4L and 6). Although the molecular mechanisms underlying this reduced expression remain to be clarified, it seems to be caused by accelerated degradation by the ubiquitin proteasome pathway ( Figure 4K and 6G) . Further, the knockdown of MURF1 in nsh mutants partially recovered the cardiac systolic and diastolic velocity.
These studies therefore suggests the inhibition of MURF1 function as a therapeutic intervention for HCM patients.
In summary, we have identified TTN mutations that increased the binding of titin to MURF1 in a 
Materials and methods
Fish strains and maintenance
Medaka fish (Oryzias latipes) were maintained at 28.5°C in a recirculating system with a 14-h/day and 10-h/night cycle. The Qurt strain, derived from the southern Japanese population was used for the genetic screen. Another strain, Kaga, which came from the northern population in Japan, was used for the mapping cross. The medaka heart mutant non-spring heart (nsh) was isolated by mutational screening. 22 Fertilized eggs were collected and then incubated at 28.5°C in medaka Ringer's solution (0.65% NaCl, 0.04% KCl, 0.011% CaCl 2 , 0.01% MgSO 4 , 0.01% NaHCO 3 , and 0.0001% methylene blue). Developmental stages were determined by their morphology according to the medaka stage 
Counting cardiomyocytes in vivo
The DsRed2-nuc gene under control of the zebrafish cmlc2 promoter transgenic strain 25 was used for scoring cardiomyocyte numbers. The wild-type and nsh homozygous hearts carrying Tg (cmlc:
DsRed2-nuc) were dissected, fixed with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) overnight at 4°C, and then mounted in 1% agarose gel. We routinely prepared 50-100 optical sections from one heart sample, and counted cells on the merged images from one in every 25 sections.
Data were presented as mean +/-SEM. Student's t-test was used to test statistical significance.
Whole-mount RNA in situ hybridization (ISH) analysis
Whole-mount ISH analysis was performed as described previously. 26 After staining, tissues were fixed with 4% PFA in PBS for color preservation, equilibrated with 80% glycerol, and then mounted on slide glass for microscopic observation. The following primers were used for cloning the probes by 
Histology and electron microscopy
We fixed medaka embryos with 4% PFA in PBS overnight at 4°C, before dehydrating them in 70% ethanol, mounting in paraffin, and sectioning at 5 µm thickness. Sections were stained with hematoxylin and eosin (HE) and viewed using a BIOREVO optical microscope (BZ-9000; Keyence, Japan). For transmission electron microscopy, samples were prepared as described previously, 27 sectioned using an RMC MT6000 ultramicrotome, and visualized using the JEM-1230 (JEOL) electron microscope. mounted on an inverted microscope (Eclipse TE2000, Nikon, Tokyo, Japan), which was equipped with an xy scanning stage (Bios-T, Sigma Koki, Tokyo, Japan). The microscope was also equipped with a stage-top mini-incubator (WSKM, Tokai Hit, Shizuoka, Japan), which maintained the temperature of the culture plate at 28.5°C. Video of medaka embryos was recorded as sequential phase-contrast images with a 10× or 20× objective at a frame rate of 150 fps, a resolution of 2048×2048 pixels, and a depth of 8 bits.
Immunohistochemistry
Evaluation of beating heart with MVP algorithm
To evaluate cardiac systolic and diastolic motion of medaka heart from the high-speed video imaging of the embryos, we have applied MVP method as previously reported. 28, 29 Briefly, each frame was divided into square blocks of N × N pixels (Supplementary Figure IV) . Then, for a maximum motion displacement of w pixels per frame, the current block of pixels was matched to the corresponding block at the same coordinates in the previous frame within a square window of width N + 2w. 
Genetic mapping and positional cloning
Genetic mapping was performed as described previously. 30 Briefly, an nsh mutant on the Qurt genetic background was crossed with the Kaga strain to obtain F1 offspring, which were then crossed to obtain the nsh mutant embryos for mapping. A pooled bulk segregation analysis was performed to localize the nsh mutation on the medaka linkage group. 30 Further mapping was also done using custom-designed markers based on the sequence polymorphisms that differed between the Qurt and 
RT-PCR analysis
Hearts were harvested from wild-type and nsh mutant embryos (n = 50 for each) at 3 days post fertilization (dpf). Total RNA was extracted using Trizol reagent (Invitrogen). 
Cloning of titin fragment
We prepared fragments of human TTN by PCR from a TTN A156 immunoglobulin (Ig) domain construct as templates. A wild-type (WT) TTN cDNA fragment covering A156 (from bp89426 to bp89711 of NM_133378 corresponding to aa29735-aa29829) domain was obtained by PCR from cDNAs prepared from total heart RNA, and the A to T substitution mutant (E29783V mutation equivalent of the Medaka mutation Asp23186Val) was created by the primer-mediated mutagenesis method.
Constructs for epitope-tagged proteins
The cDNA fragments of WT and mutant TTN was cloned into 3HA-taggged pcDNA3-NTAP. Full length MURF1 fragment in a Myc-tagged pCMV-Tag3B construct, 32 was cloned into Flag-tagged pcDNA3-NTAP. The Myc-tagged ubiquitin construct was a kind gift from Dr. Nakada. These constructs were sequenced to ensure that no errors were introduced.
Cellular transfection, protein extraction and immunoprecipitation (IP)
A total of 8 µg of plasmid DNA was transfected into semi-confluent HEK293FT cells on 6-cm-diamitor culture dishes using Lipofectamine 2000 (Invitrogen). Epoxomicin or DMSO was added to the culture 4 h before lysate preparation. At 24 h after transfection, cells were lysed in 400 µl RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)) with protease inhibitor, incubated on ice for 30 min and centrifuged at 15000 rpm for 30 min. Supernatants were subjected to western blot (WB) and immunoprecipitation (IP). For IP, lysates were diluted 1:10 using TGN buffer (50 mM Tris-HCl pH7.5, 150 mM NaCl, 1%
Tween-20, 0.3% NP40) and precleaned by protein G PLUS-Agarose (Santa Cruz). The precleaned lysates were incubated with 1 µg Anti-HA high-Affinity (3F10, Roche) or normal IgG (GE healthcare) for 3 h and combined with 20 µl protein G PLUS-Agarose (Santa Cruz). The lysates with agarose-bead complexes were incubated overnight with rotation. The bead complexes were washed in TGN 4 times and twice in PBS. The beads were suspended in 2 x Laemmli sample buffer (BioRad) containing 15% 2-mercaptoethanol and boiled for 10 min.
Western blotting
Cellular lysates and IPs were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene fluoride (PVDF) membranes. After a pre-incubation with 3% skim milk in Tris-buffered saline (TBS), the membrane was incubated with primary antibody overnight. After TBS washing, the membrane was incubated with an appropriate secondary antibody (anti-rabbit or anti-mouse IgG HRP-conjugated Ab (1:10,000 in 3% skim milk in TBS, GE Healthcare), mouse
TrueBlot ULTRA: Anti-Mouse Ig HRP (1:1000 in 3% skim milk in TBS containing 0.1 % Tween-20 (TBST)) for 1 h. After five more washes in TBST, signals were visualized using the Chemi-Lumi One Super (Nacalai) and Luminescent Image Analyzer LAS-3000 mini (Fujifilm, Tokyo, Japan).
Antibodies
We used the following primary antibodies: First Antibodies: Flag (1:1000 in 5% BSA/TBST, M2, F7425, Sigma), HA (1:2000 in 3% skim milk/TBST, clone HA-7, Sigma), myc (1:400 in 5% BSA/TBST, clone 9E10, Santa Cruz), GAPDH (1:1000 in 5% BSA/TBST, 14C10, rabbit mAb, Cell
Singaling), and the following second antibodies: ECL anti-mouse IgG, peroxidase-linked species-specific F(ab')2 fragment (from sheep) (1:10,000 in 3% skim milk/TBST, NA9310, GE Healthcare) ECL anti-rabbit IgG, peroxidase-linked species-specific F(ab')2 fragment (from donkey)
(1:10,000 in 3% skim milk/TBST, NA9340, GE Healthcare) Mouse TrueBlot ULTRA: Anti-Mouse Ig HRP (1:1,000 in 3% skim milk/TBST, eBioscience). IPs used the anti-HA high Affinity (3F10, Roche) normal mouse IgG (GE Healthcare)
Clinical subjects
We studied 96 genetically unrelated Japanese patients with HCM, who carried apparent family history of HCM consistent with an autosomal dominant trait. They were diagnosed with HCM according to the diagnostic criteria as described previously. 33 They had been analyzed for mutations in the known disease genes for HCM, i.e., genes for contractile elements, Z-disc elements, and I band elements, and no disease-associated mutation was found. 33 Control subjects were 400 healthy Japanese individuals selected at random. Blood samples were obtained from the subjects after written informed consent and the research protocol was approved by the Ethics Review Committee of Medical Research Institute, Tokyo Medical and Dental University, Japan.
Mutational analysis
Genomic DNA extracted from blood samples of each individual was subjected to PCR in exon-by-exon manner by using primer-pairs specific to exons 296 to 307 of TTN (GenBank Accession
No. NM_133378), which encode for titin at the A-band-M-line transition zone including the titin-kinase domain. Sequences of primers and PCR conditions used in this study are listed in Supplementary Table 1 . PCR products were analyzed by direct sequencing using Big Dye Terminator chemistry (Applied Biosystems) and an ABI3100 DNA analyzer (Applied Biosystems).
Co-immunoprecipitation assay
We used cDNA fragments of human TTN and MURF1 by PCR from TTN A156, A160-161, and A168-170 immunoglobulin (Ig)-like domain constructs and a MURF1 full-length construct, respectively, as templates for PCR. A wild-type (WT) TTN cDNA fragment covering A156 (from bp89426 to bp89711 of NM_133378 corresponding to aa29735-aa29829), A160-161 (from bp90626 to bp91202 corresponding to aa30134-aa30326), A168 (from bp93006 to bp93287 corresponding to aa30928-aa31021), A169 (from bp93288 to bp93581 corresponding to aa31022-aa31119), or A168-A170 (from bp93006 to bp93908 corresponding to aa30928-aa31228) domains was obtained by PCR, and TTN mutants carrying A to T (E29783V mutation equivalent of the medaka mutation D23186V), T to G (an HCM-associated S30186A mutation), or T to A (another HCM-associated D30994N mutation) substitutions were created by the primer-mediated mutagenesis method. A full-length MURF1 cDNA fragment spanning from bp137 to bp1198 of GenBank Accession No.
NM_032588 (corresponding to aa1-aa354) was obtained by PCR. The TTN cDNA fragment was cloned into pEGFP-C1 (Clontech, CA, USA), while the MURF1 cDNA fragment was cloned into myc-tagged pCMV-Tag3 (Stratagene, CA, USA). These constructs were sequenced to ensure that no errors were introduced.
Cellular transfection and protein extraction were performed as described previously, 33 of less than 0.05 was considered to be statistically significant.
In vitro ubiquitination assay
In vitro ubiquitination reactions contained as E1 ligase 100 nM UBE1 (Boston Biochem), and 1µM Kanrinmaru project, Japan.
Disclosures
None.
Figure 1.
Hypertrophic myocardium and disrupted sarcomeric structure in the medaka nsh mutant heart. A and B, Morphology of the wild-type (WT) and nsh mutant heart at 3 days post fertilization (dpf).
The mutant showed hypertrophic heart, especially in the atrium (double-headed arrow). The nsh heart lost elasticity and showed increased passive stiffness. Due to diastolic inability (see supplemental Movie 2), the blood flow was very slow or clogged around 3 dpf. C and D, Confocal Z-stacked images of the WT and nsh mutant hearts at 3 dpf, in which cardiomyocytes were visualized by the Tg signal (cmlc2: DsRed2-nuc).
These reconstructed confocal images show approximately half of the total cardiomyocytes. E, Quantification of cardiomyocytes using the transgenic line. Cell counting was performed on the optical slices to attain an accurate count. There was no difference in the number of cardiomyocytes between the WT and nsh mutant hearts. NS, statistically not significant (n = 5 for WT and nsh). F through K, In situ RNA hybridization analysis showing cardiac myosin light chain 2 (cmlc2) (F and G), atrial and ventricular myosin heavy chains (amhc and vmhc, respectively) (H and I), in the WT and nsh mutant at 3 dpf. Normal sarcomeric protein expression was observed in the nsh mutant. J and K, Strong expression of brain natriuretic peptide (bnp) was detected at 3 dpf in the WT ventricle (J), whereas bnp expression was strong in the atrium of nsh mutants (K). L and M, Transmission electron microscopic findings of medaka embryonic cardiomyocytes at 5 dpf. Myofibrillar arrays were evident in the WT heart (L), but myofibrils were reduced with loosely arranged contractile filaments in the nsh mutant (nsh -/-) (M). Thick filament structures and integrity of M-line region were disrupted, and Z-discs were not parallel. N and O, Medaka adult cardiac myocytes in the WT and nsh heterozygotes (nsh +/-) were stained for α -actinin. Expression of sarcomeric α -actinin was maintained in the nsh heterozygous mutant, but fewer striations and patchy staining were observed (O). P and Q, Transmission electron microscopy showed the rupture of sarcomeric units, as well as irregular and widened Z-discs and M-lines in cardiomyocytes of the nsh heterozygotes. The integrity of the thick filaments is disrupted (Q). a, atrium; v, ventricle; Myo, myocardium. Z-discs (arrowhead) and M-lines (arrow) are indicated. Scale bars, 50 µm in (A through D), 1 µm in (L and M), 5 µm in (N and O), and 0.5 µm in (P and Q). A, RT-PCR analysis of TTN for N-terminal portion, A-I junction region, exon 204, and titin kinase domain in the WT and nsh mutant embryos at 3 dpf. Despite the presence of missense mutation, level of TTN mRNAs for these portions in the nsh mutant was similar to that in the WT. ef1α was used as a control. B, RT-PCR analysis of titin N2B isoforms in the WT and nsh mutants. N2B isoforms were increased. C through F, Embryonic skeletal muscle of the WT and nsh mutant at 3 dpf were stained with antibodies to A-I junction titin (C and D) and C-terminal titin (E and F). Despite the similar expression level of TTN mRNA, expression of titin containing the A-I junction isoform was reduced (D). Sarcomeric structures were disrupted in the nsh mutant (F). G through J, WT and mutant (E29783V which was the equivalent of D23186V mutation in medaka) Ig fragments mRNA injection to Medaka embryos. Despite the same amount of mRNA injection, mutant (E29783V) Ig fragments degraded faster than WT TTN Ig fragments. K, Western blots (WB) of HEK293FT cells transfected with HA-tagged WT and mutant (E29783V) Ig fragments with or without a proteosome inhibitor, epoxomicin. Myc-tagged ubiquitin was co-transfected to visualize the ubiquitination. WB of anti-HA IPs and control normal IgG IPs. Note the myc-labeled large molecules in mutant TTN transfectants were present only in the presence of epoxomicin. L, GFP-tagged TTN-A156 domain co-precipitated with myc-tagged MURF1 are shown (top panel). Expression levels of GFP-tagged TTN-A156 (middle panel) and myc-tagged MURF1 (lower panel) was confirmed by WB of whole cell lysates. Binding pairs were WT or E29783V mutant TTN-A156 in combination with MURF1. Dashes indicate no myc-tagged proteins (transfected only with pCMV-Tag3). M, Densitometric data obtained from the co-IP assays. Bar graphs indicate the amount of IPs normalized to the input amount of GFP-TTN. Value for WT TTN-A156 with MURF1 was arbitrarily defined as 1.00 arbitrary unit (AU). Data are represented as means +/-SEM. (n = 10). ** P<0.001 vs WT. Representative frontal view of a WT heart at 5 dpf. Atrium was on this side and ventricle was deeper side. Blood flow was observed in the myocardial wall.
Movie 2. Contracting heart of a nsh mutant embryo.
Representative frontal view of a mutant heart at 5 dpf. The nsh mutant heart had lost elasticity, beat in a rigid manner and showed increased thickening of the myocardial wall, even without blood flow.
Supplemental Figure I Normal vascular formation was observed in the nsh mutant.
Crossing with fli1-GFP transgenic medaka revealed normal vascular endothelial cells and normal blood vessel formation in the WT and nsh mutant at 3 dpf. Scale bars, 200 µm. 
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